Phase 1/2a First-In-Human Study of BMS-986218 Monoclonal Antibody Alone and in Combination with Nivolumab in Advanced Solid Tumors

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
Phase 1/2a First-In-Human Study of BMS-986218 Monoclonal Antibody Alone and in Combination with Nivolumab in Advanced Solid Tumors

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.